Is there a common molecular pathway for addiction?
The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Drugs of abuse have very different acute mechanisms of action but converge on the brain's reward pathways by producing a series of common functional effects after both acute and chronic administration. Some similar actions occur for natural rewards as well. Researchers are making progress in understanding the molecular and cellular basis of these common effects. A major goal for future research is to determine whether such common underpinnings of addiction can be exploited for the development of more effective treatments for a wide range of addictive disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, repeated substance use activates accumulating levels of ΔFosB, and animals with elevated ΔFosB exhibit exaggerated sensitivity to the rewarding effects of drugs of abuse, leading to the hypothesis that ΔFosB might be a sustained molecular trigger or switch that helps initiate and maintain a state of addiction.141,142”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [141]
In the citing paper
“Thus, dopamine release causes a pleasurable experience that is critical for reinforcing the effects of tobacco and nicotine dependence”
From Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits (2023) · cites this paper as [25]
In the citing paper
“There is evidence that all addictions, both drug-related and behavioral, result from a common mechanism in the brain [26].”
From Social Media Algorithms and Teen Addiction: Neurophysiological Impact and Ethical Considerations (2025) · cites this paper as [26]
In the citing paper
“Recent studies indicate that compulsive sexual arousal may be addictive and hazardous to otherwise healthy people because it has neurological effects on the brain that are comparable to those of drugs (Love et al., 2015;Nestler, 2005;Phillips et al., 2015;Reisman, 2004;Voon et al., 2014).”
From “Your Addiction, her Sexual Suffering”—A Qualitative Inquiry into the Effects of Compulsive Sexual Behaviors on Intimate Female Partners (2025) · cites this paper as Nestler, 2005
In the citing paper
“One of the most dramatic examples of protein expression induction is in the transcription factor ΔFosB, a Fos family protein, which accumulates in the NAc after chronic exposure to drugs of abuse, including alcohol, amphetamine, cannabinoids, cocaine, nicotine, opiates, and phencyclidine [86,87].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [86]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053570 · Cited by 1,859
Self-citationRobinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
CARLEZONJR, W., DUMAN, R., & NESTLER, E. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,346 · cited 1×
“Despite this opposite regulation of CREB in the NAc by different drugs, activation of CREB seems to produce similar behavioral effects: in numerous experimental systems, increased CREB activity in the NAc decreases behavioral responses to cocaine, opiates and alcohol, whereas decreased CREB activity increases such res…”
BackgroundSelf-citationAddiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
Adaptive Coding of Reward Value by Dopamine Neurons
Tobler, P. N., Fiorillo, C. D., & Schultz, W. (2005) · Science · doi:10.1126/science.1105370 · Cited by 1,276 · cited 1×
“Growing evidence indicates that the VTA-NAc pathway and the other limbic regions cited above similarly mediate, at least in part, the acute positive emotional effects of natural rewards, such as food, sex and social interaction”
BackgroundDrugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147 · cited 1×
“Numerous types of drugs of abuse, including cocaine, amphetamine, opiates, alcohol or nicotine, induce a long-term potentiation (LTP)-like state in VTA dopamine neuron”
The Neuroscience of Natural Rewards: Relevance to Addictive Drugs
Kelley, A. E., & Berridge, K. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03306.2002 · Cited by 1,123 · cited 1×
“Growing evidence indicates that the VTA-NAc pathway and the other limbic regions cited above similarly mediate, at least in part, the acute positive emotional effects of natural rewards, such as food, sex and social interaction”
BackgroundStructural plasticity associated with exposure to drugs of abuse
Robinson, T. E., & Kolb, B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.025 · Cited by 1,113 · cited 1×
“Chronic exposure to cocaine, amphetamine or nicotine causes long-lasting increases in dendritic arborization and in the density of dendritic spines of these neuron”
Background
Cited by
Items 501–600 of 1,001
Fisher, M. L., LeMalefant, R., Zhou, L., Huang, G., & Turner, J. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.257 · Cited by 33
“Previous studies suggest the involvement of CREB (cAMP-responsive element binding protein)-dependent transcription in the molecular mechanism of dependence on multiple drugs of abuse, including nicotine (Nestler, 2005).”
BackgroundLiu, X., Gao, S., Zhang, N., Jin, T., Sun, X., Luan, X., Xu, L., & Guo, F. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102028 · Cited by 34
Xiang, K., Earl, D. E., Davis, K. M., Giovannucci, D. R., Greenfield, L. J., & Tietz, E. I. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144444 · Cited by 35
“In midbrain striatal dopamine pathways, activation of L-VGCC calcium influx is proposed to activate downstream Ca(2) /calmodulinactivated kinase and phosphatase pathways, eventually involving cAMP response element-binding protein-induced gene expression, and psychostimulant-induced plasticity (Nestler, 2005; Rajadhyak…”
BackgroundGray, J. C., & MacKillop, J. (2014) · Brain and Behavior · doi:10.1002/brb3.284 · Cited by 31
“…future studies should seek to explore the role of other upstream systems implicated in the reward pathway such as GABA and glutamate, which are known to inner-vate dopamine neurons in central regions of the mesolimbic system, the ventral tegmental area and the nucleus accumbens (Nestler 2005).”
Bellone, C., & Lüscher, C. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00075 · Cited by 35
“DRUG-DEPENDENT TRAFFICKING OF GLUTAMATE RECEPTORS In the mesocorticolimbic DA system, which originates from the DA neurons of VTA that project onto the nucleus accumbens (NAc) and prefrontal cortex (PFC), many common cellular adaptations have been described following drug exposure (Nestler, 2005).”
BackgroundTranscriptomic Characterization of the Human Insular Cortex and Claustrum
Ibrahim, C., Foll, B. L., & French, L. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00094 · Cited by 33
Role of Long Noncoding RNA Gas5 in Cocaine Action
Xu, H., Brown, A. N., Waddell, N. J., Liu, X., Kaplan, G. J., Chitaman, J. M., Stockman, V., Hedinger, R. L., Adams, R., Abreu, K., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.004 · Cited by 35
“Repeated use of drugs leads to enduring cellular and molecular changes in the brain’s reward circuitry, particularly in nucleus accumbens (NAc), part of the ventral striatum (1, 2).”
BackgroundSelf-citationSubstance use disorders: a theory‐driven approach to the integration of genetics and neuroimaging
Karoly, H. C., Harlaar, N., & Hutchison, K. E. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12074 · Cited by 35
Resting state brain connectivity patterns before eventual relapse into cocaine abuse
Berlingeri, M., Losasso, D., Girolo, A., Cozzolino, E., Masullo, T., Scotto, M., Sberna, M., Bottini, G., & Paulesu, E. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.002 · Cited by 34
Vallender, E. J., Goswami, D. B., Shinday, N. M., Westmoreland, S. V., Yao, W., & Rowlett, J. K. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.01.030 · Cited by 33
“The mesolimbic dopamine system, connecting the ventral tegmental area (VTA) and the nucleus accumbens (NAc), drives the salient effects of reward and has been consistently and repeatedly shown to be the primary site of action of drugs of abuse (Nestler, 2005).”
Ferreira, G. K., Cardoso, E., Vuolo, F. S., Galant, L. S., Michels, M., Gonçalves, C. L., Rezin, G. T., Dal‐Pizzol, F., Benavides, R., Alonso-Núñez, G., et al. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.05.110 · Cited by 35
The Dopaminergic Projection System, Basal Forebrain Macrosystems, and Conditioned Stimuli
Zahm, D. S., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900016138 · Cited by 34
García-Fuster, M. J., Clinton, S. M., Watson, S. J., & Akil, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.88 · Cited by 35
“Cocaine addiction is both mental and physical, and largely depends on drug-induced neurochemical, structural, and behavioral brain alterations (”
BackgroundTian, G., Hui, M., Macchia, D., Derdeyn, P., Rogers, A., Hubbard, E., Liu, C., Vasquez, J. J., Taniguchi, L., Bartas, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110775 · Cited by 31
“Although the majority of addiction research has been focused on how drug-evoked DA release in the NAc contributes to drug reward (Di Chiara et al., 2004; Koob and Le Moal, 2001; Nestler, 2005; Volkow et al., 2004; Wise, 2004), DA is involved in a wide array of other addiction-related processes.”
Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats
Ryan, P. J., Krstew, E., Sarwar, M., Gundlach, A. L., & Lawrence, A. J. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.04.017 · Cited by 35
“…terminalis, thalamic and hypothalamic paraventricular nuclei and lateral hypothalamus (Koob, 2008; Lawrence, 2010; Martin-Fardon and Boutrel, 2012; Nestler, 2005; Smith et al., 2011), which largely coincides with the distribution of RXFP3 expressing neurons (Ma et al., 2007; Sutton et al., 2004).”
BackgroundSemenkovich, K. A., Chockalingam, R., Scherrer, J. F., Panagopoulos, V. N., Lustman, P. J., Ray, J. M., Freedland, K. E., & Švrakić, D. M. (2014) · Europe PMC (PubMed Central) · Cited by 39
Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_29-1 · Cited by 42
Kurokawa, K., Mizuno, K., Shibasaki, M., & Ohkuma, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07010.x · Cited by 32
Behavioral and Neurochemical Studies in Distinct Animal Models of Ethanols Motivational Effects
Camarini, R., Pautassi, R. M., Méndez, M., Quadros, I. M., Formigoni, M. L. O. D. S., & Boerngen-Lacerda, R. (2010) · Current Drug Abuse Reviews · doi:10.2174/1874473711003040205 · Cited by 36
Sex, ADHD symptoms, and smoking outcomes: An integrative model
Voorhees, E. E. V., Mitchell, J. T., McClernon, F. J., Beckham, J. C., & Kollins, S. H. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.01.034 · Cited by 37
Drug Addiction and DNA Modifications
Brown, A. N., & Feng, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_6 · Cited by 31
Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction
Cross, A. J., Anthenelli, R. M., & Li, X. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.021 · Cited by 33
“Thus, glutamatergic neurotransmission within the mesocorticolimbic system is likely involved in the development of drug dependence, withdrawal, and expression of drug seeking (81, 82).”
BackgroundEDITORIAL: Ghrelin: a link between energy homeostasis and drug abuse?
Cummings, D. E., Naleid, A. M., & Lattemann, D. F. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00053.x · Cited by 33
“Although different drugs and natural rewards have very diverse initial mechanisms and sites of action, most or all of them engage neural circuits that impinge upon the mesolimbic DA system (Nestler 2005).”
BackgroundInfluentialKamens, H. M., McKinnon, C. S., Li, N., Helms, M. L., Belknap, J. K., & Phillips, T. J. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00444.x · Cited by 31
“These regions were chosen because they are part of the motive circuit (Nestler 2005) known to modulate drug-induced locomotor stimulation (Wise & Bozarth 1987).”
BackgroundCadherins mediate cocaine-induced synaptic plasticity and behavioral conditioning
Mills, F., Globa, A. K., Liu, S., Cowan, C. M., Mobasser, M., Phillips, A. G., Borgland, S. L., & Bamji, S. X. (2017) · Nature Neuroscience · doi:10.1038/nn.4503 · Cited by 32
Fouyssac, M., & Belin, D. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14416 · Cited by 31
“Drugs of abuse induce a broad spectrum of central and systemic effects that vary depending on their mechanisms of action (Nestler, 2005).”
BackgroundChapter 10 Regulators of G Protein Signaling in Neuropsychiatric Disorders
Terzi, D., Stergiou, E., King, S. L., & Zachariou, V. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)86010-9 · Cited by 32
Taqi, M. M., Bazov, I., Watanabe, H., Nyberg, F., Yakovleva, T., & Bakalkin, G. Y. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.042 · Cited by 30
Roberts, V., Gant, N., Sollers, J. J., Bullen, C., Jiang, Y., & Maddison, R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3742-8 · Cited by 30
Darland, T., Mauch, J. T., Meier, E. M., Hagan, S. J., Dowling, J. E., & Darland, D. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.07.017 · Cited by 34
“…genes such as the calcium response element binding protein (CREB), FosB, DA related protein phosphatase (DARPP-32) and the dopamine transporter, among others shown to be rapidly regulated by cocaine in mammals, to see how conserved the reward pathway is in teleosts (Nestler 2004; Nestler 2005).”
BackgroundInfluence of nonsynaptic α1 glycine receptors on ethanol consumption and place preference
Muñoz, B., Gallegos, S., Peters, C., Murath, P., Lovinger, D. M., Homanics, G. E., & Aguayo, L. G. (2019) · Addiction Biology · doi:10.1111/adb.12726 · Cited by 31
“The most conventional action of ethanol on the mesolimbic dopamine system considers GABAAR activation as the main inhibitory synaptic transmission in MSNs and interneurons.(6) Studies have shown that application of dopamine on NAc slices affected nonsynaptic GABAARs, without changing those synaptically located.”
BackgroundJiang, W., Xiao, J., Li, M., Deng, H., Jiang, T., Xiong, K.-Z., Chen, Y., Wang, X.-F., & Wang, Q. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173397 · Cited by 30
Drug specificity in extended access cocaine and heroin self‐administration
Lenoir, M., Guillem, K., Koob, G. F., & Ahmed, S. H. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00385.x · Cited by 35
“For instance, Nestler and colleagues have demonstrated that chronic exposure to many drugs of abuse, including cocaine and morphine, induces the accumulation of the transcription factor deltaFosB in the nucleus accumbens that contributes to the long-term persistence of plasticity (Nestler 2005).”
BackgroundPinheiro, C. R., de Moura, E. G., Manhães, A. C., Fraga, M. C., Claudio-Neto, S., Younes-Rapozo, V., Santos-Silva, A. P., Denucci, B. L., Oliveira, E., & Lisboa, P. C. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.05.040 · Cited by 30
Sadek, S. M., Khatri, S., Kipp, Z. A., Dunn, K. E., Beckmann, J. S., Stoops, W. W., Hinds, T. D., & Gipson, C. D. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109816 · Cited by 29
“…ventral tegmental area (VTA; Mejias-Aponte et al., 2009) , a brain region that contains dopamine cell bodies and plays a critical role in drug use (Nestler, 2005), and A2aR agonism increases the regularity of VTA dopamine (DA) cell firing (Grenhoff and Svensson, 1989) and also decreases opioid…”
BackgroundDoes the General Strain Theory Explain Gambling and Substance Use?
Greco, R., & Curci, A. (2016) · Journal of Gambling Studies · doi:10.1007/s10899-016-9654-2 · Cited by 33
“…inclusion of Behavioral Addictions inside Substance-Related Disorder category is the similarity in subjective experience, clinical presentation, neurobiological substrate, and treatment indications between behavioral and substance addiction (Comings and Blum 2000; Nestler 2005; Nutt et al. 2015).”
BackgroundTreating cocaine and opioid use disorder with transcranial magnetic stimulation: A path forward
Steele, V. R., & Maxwell, A. M. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173240 · Cited by 31
Swimmer, K. R., & Sandelich, S. (2023) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2023.06.023 · Cited by 33
Peoples, L. L., Kravitz, A. V., Lynch, K. G., & Cavanaugh, D. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301203 · Cited by 30
“…al, 2003), and receptors (Przegaliñski et al, 2003; Ricci et al, 2004) as well as evidence of postsynaptic changes in signal transduction, gene transcription factors (McClung and Nestler, 2003; Nestler, 2005) and cell morphology (Robinson et al, 2001; Ferrario et al, 2005; Norrholm et al, 2003).”
BackgroundMethylphenidate administration determines enduring changes in neuroglial network in rats
Cavaliere, C., Cirillo, G., Bianco, M. R., Adriani, W., Simone, A. D., Leo, D., Perrone‐Capano, C., & Papa, M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.003 · Cited by 31
“Repeated exposure to psychostimulant drugs causes complex molecular, structural and plastic modifications in the brain reward circuitry (Nestler, 2005; Berman et al., 2008; Haydon et al., 2009), in both neuronal and glial compartments of the tripartite synapse (Araque et al., 1999; Newman, 2003;…”
InfluentialLi, Q., Shi, L., Lü, G., Hong-luan, Y., Yeung, F.-K., Wong, N.-K., Sun, L., Liu, K., Yew, D. T. W., Pan, F., et al. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00285 · Cited by 32
“, 1992), a growing number of brain imaging studies have shown that the frontal white matter abnormalities may be as a fundamental change in patients with chronic drug dependence (Nestler, 2005; Wang et al., 2013).”
BackgroundSpinal pathways involved in somatosensory inhibition of the psychomotor actions of cocaine
Chang, S., Ryu, Y., Gwak, Y. S., Kim, N. J., Kim, J. M., Lee, J. Y., Kim, S. A., Lee, B. H., Steffensen, S. C., Jang, E. Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05681-7 · Cited by 33
“Briefly: (1) dorsal column lesions were made bilaterally to a depth of 0.”
Therapeutic Targeting of “DARPP-32”
Mahajan, S. D., Aalinkeel, R., Reynolds, J. L., Nair, B. B., Sykes, D. E., Hu, Z., Bonoiu, A. C., Ding, H. Y., Prasad, P. N., & Schwartz, S. A. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88008-2 · Cited by 30
“…stimulation leading to induction of transcription factors and phosphorylation of many substrate proteins involved in neuronal excitability (Colvis et al., 2005; Fienberg et al., 1998, 2000; Greengard et al., 1998; Guitart-Masip et al., 2006; Nestler, 2005; Nestler et al., 1994; Self et al., 1998).”
BackgroundPerinatal overnutrition and the programming of food preferences: pathways and mechanisms
Ong, Z. Y., Gugusheff, J., & Mühlhäusler, B. S. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s204017441200030x · Cited by 30
“These dopaminergic neurons project to the NAc where dopamine is released.(14) Termination of dopamine signalling occurs through active reuptake of dopamine by dopamine active transporters (DAT).”
BackgroundPalomino, A., Pavón, F. J., Blanco, E., Serrano, A., Arrabal, S., Rivera, P., Alén, F., Vargas, A., Bilbao, A., Rubio, L., et al. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00022 · Cited by 29
Interventions to prevent periodontal disease in tobacco‐, alcohol‐, and drug‐dependent individuals
Kumar, P. (2020) · Periodontology 2000 · doi:10.1111/prd.12333 · Cited by 30
Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction
Malik, J. A., & Agrewala, J. N. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110210 · Cited by 28
Dopamine D4receptor activation decreases the expression of μ‐opioid receptors in the rat striatum
Gago, B., Fuxé, K., Agnati, L. F., Peñafiel, A., de la Calle, A., & Rivera, A. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21327 · Cited by 31
“Dysfunction of mesolimbic DA systems has been associated with the development of opioid dependence (Nestler, 2004, 2005), whereas the dysfunction of the nigrostriatal DA system contributes to the development of stereotyped behavior (Morelli et al., 1989).”
BackgroundXie, X., Xu, L., Liu, H., Chen, W., Zhuang, D., Zhang, J., Duan, S., & Zhou, W. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.049 · Cited by 28
Gago, B., Suárez‐Boomgaard, D., Fuxé, K., Brené, S., Reina‐Sánchez, M. D., Rodríguez‐Pérez, L., Agnati, L. F., de la Calle, A., & Rivera, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.046 · Cited by 31
Global Approaches to the Role of miRNAs in Drug-Induced Changes in Gene Expression
Eipper-Mains, J. E., Eipper, B. A., & Mains, R. E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00109 · Cited by 29
“Abundant evidence, from both animals and humans, identifies the limbic system as the convergence point for the actions of all drugs of abuse (Koob and Le Moal, 2001; Nestler, 2001, 2005b; Di Chiara, 2002; Volkow et al., 2004; Wise, 2004).”
BackgroundThe Firepower of Work Craving: When Self-Control Is Burning under the Rubble of Self-Regulation
Wojdyło, K., Baumann, N., & Kühl, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169729 · Cited by 29
Gao, X., Wang, Y., Lang, M., Li, Y., Reece, A. S., & Wang, W. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0057 · Cited by 29
“Dopamine is a major neurotransmitter that triggers the rewarding effects of opioids, and the pursuit of euphoria and these effects are the initial factors contributing to addiction (Nestler, 2005).”
da-Rosa, D. D., Valvassori, S. S., Steckert, A. V., Arent, C. O., Ferreira, C. L., Lopes-Borges, J., Varela, R. B., Mariot, E., Dal‐Pizzol, F., Andersen, M. L., et al. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0691-9 · Cited by 30
“Excessive stimulation of dopamine receptors during exposure to psychostimulants induces various molecular adaptive changes in the mesolimbic dopamine pathway (White and Kalivas 1998; Nestler 2005 ), which may explain this difference between the treatments acute and chronic with m-AMPH in the doses of (0.25, 0.5 and 1…”
BackgroundInfluentialMegerdichian, C., Rees, V. W., Wayne, G. F., & Connolly, G. N. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701648458 · Cited by 30
Young, K. A., Liu, Y., Gobrogge, K. L., Dietz, D. M., Wang, H., Kabbaj, M., & Wang, Z. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.109 · Cited by 27
Hällfors, J., Palviainen, T., Surakka, I. L., Gupta, R., Buchwald, J., Raevuori, A., Ripatti, S., Korhonen, T., Jousilahti, P., Madden, P. A. F., et al. (2018) · Addiction Biology · doi:10.1111/adb.12618 · Cited by 28
“Stimulation of nAChRs induces the release of various neurotransmitters, such as dopamine, which has a key role in drug-induced reward by creating the perceptions of pleasure and reward (Nestler 2005).”
BackgroundAL-Eitan, L. N., Jaradat, S. A., Su, S., Tay, G. K., & Hulse (2012) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s33351 · Cited by 30
“59 These studies have shown that the endogenous opioid system in particular is considered to be one of the most important signaling pathways involved in opiate dependence.”
Atkinson, N. S. (2009) · Journal of Neurogenetics · doi:10.1080/01677060802572937 · Cited by 34
Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens
Ambrose‐Lanci, L. M., Peiris, N., Unterwald, E. M., & Bockstaele, E. J. V. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.105 · Cited by 30
“Neuroadaptations in cell signaling pathways following chronic cocaine administration may contribute to an increased likelihood of relapse (Nestler, 2005).”
BackgroundInfluentialDopamine D3 receptors regulate reconsolidation of cocaine memory
Yan, Y., Kong, H., Wu, E., Newman, A. H., & Xu, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.005 · Cited by 31
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
“The mesolimbic dopamine system is commonly believed to be the most important and classical mechanism shared by all addictive substances (Nestler, 2005).”
BackgroundAn overview of ghrelinO-acyltransferase inhibitors: a literature and patent review for 2010-2019
Moose, J. E., Leets, K. A., Mate, N. A., Chisholm, J. D., & Hougland, J. L. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1776263 · Cited by 26
Sierra, S., Muchhala, K. H., Jessup, D. K., Contreras, K. M., Shah, U. H., Stevens, D. L., Jimenez, J., Lavilla, X. K. C., Revenga, M. D. L. F., Lippold, K. M., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108988 · Cited by 27
Biała, G., & Budzyńska, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70340-6 · Cited by 26
“reinforcement [28, 39].”
Rezin, G. T., Furlanetto, C. B., Scaini, G., Valvassori, S. S., Gonçalves, C. L., Ferreira, G. K., Jeremias, I. C., Resende, W. R., Cardoso, M. R., Varela, R. B., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8566-8 · Cited by 29
“mesolimbic dopamine pathway [73, 74].”
Lloyd, S. A., Oltean, C., Pass, H. I., Phillips, B., Staton, K., Robertson, C. L., & Shanks, R. A. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.038 · Cited by 28
“Further support pairs molecular markers of plasticity in these areas of the brain with drug-induced inhibitory control deficits and addiction [27,28,50,51].”
BackgroundKesby, J. P., Hubbard, D. T., Markou, A., & Semenova, S. (2012) · Addiction Biology · doi:10.1111/adb.12023 · Cited by 26
“…reward circuits in the brain, particularly the mesolimbic dopamine pathway, are crucial for the © 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction Addiction Biology, 19, 593–605 initiation and maintenance of drug use (Di Chiara 2002; Nestler 2005; Berridge 2007).”
BackgroundDeehan, G. A., Knight, C. P., Waeiss, R. A., Engleman, E. A., Toalston, J. E., McBride, W. J., Hauser, S. R., & Rodd, Z. A. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agw037 · Cited by 26
“Specifically, DA signaling within the VTA–Acb projection has been identified as a key component of the rewarding actions of virtually every major drug of abuse including alcohol (EtOH; Nestler, 2005).”
Dogra, S., Kumar, A., Umrao, D., Sahasrabuddhe, A. A., & Yadav, P. N. (2016) · Scientific Reports · doi:10.1038/srep33401 · Cited by 27
“05) as well as Dynorphin A (1-13) (Supplementary Fig.”
BackgroundCarboni, L., Romoli, B., Bate, S. T., Romualdi, P., & Zoli, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.027 · Cited by 28
Nicotine Use Disorders in Adolescents
Cavallo, D. A., & Krishnan‐Sarin, S. (2019) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2019.08.002 · Cited by 27
Chiappetta, S., Stier, C. K., Hadid, M. A., Malo, N., Theodoridou, S., Weiner, R. A., & Weiner, S. R. (2020) · Obesity Facts · doi:10.1159/000506838 · Cited by 27
Just What Lies “Beyond the Pleasure Principle”?
Johnson, B. (2008) · Neuropsychoanalysis · doi:10.1080/15294145.2008.10773588 · Cited by 28
Sex heterogeneity in pharmacogenetic smoking cessation clinical trials
Schnoll, R. A., & Patterson, F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.012 · Cited by 26
Fabbricatore, A. T., Ghitza, U. E., Prokopenko, V. F., & West, M. O. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07033.x · Cited by 28
“structure of the NAcc, the ventral pallidum, has been described as a common neurophysiological event in the administration of most, if not all, drugs of abuse (Wise, 2002; Nestler, 2005).”
BackgroundAltered Reward Circuitry in the Norepinephrine Transporter Knockout Mouse
Gallagher, J. J., Zhang, X., Hall, F. S., Uhl, G. R., Bearer, E. L., & Jacobs, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057597 · Cited by 25
van Duijvenbode, N., Didden, R., Korzilius, H. P. L. M., & Engels, R. C. M. E. (2015) · Journal of Intellectual Disability Research · doi:10.1111/jir.12244 · Cited by 28
Genome-wide DNA methylation differences in nucleus accumbens of smokers vs. nonsmokers
Markunas, C. A., Semick, S. A., Quach, B. C., Tao, R., Deep‐Soboslay, A., Carnes, M. U., Bierut, L. J., Hyde, T. M., Kleinman, J. E., Johnson, E. O., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0782-0 · Cited by 27
Li, J., Sun, Y., & Ye, J.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040347 · Cited by 29
“Many studies have proposed that the persistent activation of DFosB may be a common pathway for addictive disorders [32].”
BackgroundSerum Brain-Derived Neurotrophic Factor Levels and Cocaine-Induced Transient Psychotic Symptoms
Corominas, M., Roncero, C., Eiroá‐Orosa, F. J., Ribasés, M., Barral, C., Daigre, C., Martínez‐Luna, N., Sánchez‐Mora, C., Ramos‐Quiroga, J. A., & Casas, M. (2013) · Neuropsychobiology · doi:10.1159/000353259 · Cited by 29
A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats
Boules, M., Oliveros, A., Liang, Y., Williams, K., Shaw, A. M., Robinson, J. L. L., Fredrickson, P. A., & Richelson, E. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.09.003 · Cited by 27
“Abrupt withdrawal from any drug of abuse leads to an increase in CRF-containing neurons in the amygdale (Heinrichs and Koob, 2004), which partly mediates the negative emotional and somatic symptoms related to withdrawal (Nestler, 2005).”
BackgroundNowicki, M., Tran, S., Chatterjee, D., & Gerlai, R. T. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.09.008 · Cited by 27
“One, common underpinnings of addiction can be exploited for the development of more effective treatments for many addictive disorders (Nestler, 2005), a goal in addiction research that is already beginning to be explored.”
BackgroundMolecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 26
“The development of addiction involves not only the acute rewarding effects of a drug but long-term molecular adaptations in neural circuits.(83) ARTICLE IN PRESS”
BackgroundAbiero, A., Botanas, C. J., Custodio, R. J. P., Sayson, L. V., Kim, M., Lee, H. J., Kim, H. J., Lee, K. W., Jeong, Y., Seo, J., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05412-y · Cited by 26
“Its activity, particularly in the NAc, can be altered by repeated exposure to several drugs of abuse (Nestler 2004, 2005, 2012).”
Lee, G., Kikuno, K., Bahn, J.-H., Kim, K., & Park, J. H. (2013) · Chronobiology International · doi:10.3109/07420528.2012.741169 · Cited by 26
“It was reported in mice that the expression of DA receptors and DAT exhibits circadian oscillation in dopaminergic neurons (Nestler, 2005; Weber et al., 2004; Wise, 1998).”
BackgroundEndogenous Modulators for Drug Dependence
Yamada, K. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1635 · Cited by 25
Ren, X., Lutfy, K., Mangubat, M., Ferrini, M. G., Lee, M. L., Liu, Y., & Friedman, T. C. (2013) · Journal of Obesity · doi:10.1155/2013/764742 · Cited by 25
“CREB is found in most tissues examined, with high levels in the brain [4] and is thought to be an important mediator in substance abuse [5, 6].”
BackgroundJacobs, M. M., Murray, J., Byrd, D., Hurd, Y. L., & Morgello, S. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0204-8 · Cited by 26
“With chronic substance dependence, adaptive brain changes occur, most notably reduced tonic dopamine levels and increased phasic dopamine neurotransmission following drug dependence (Nestler 2005).”
BackgroundPtchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking
Maza, N. A., Wang, D., Kowalski, C. W., Stoveken, H. M., Dao, M. T., Sial, O. K., Giles, A. C., Grill, B. J., & Martemyanov, K. A. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01135-0 · Cited by 24
Brembach, T.-C., Sabat, R., Witte, K., Schwerdtle, T., & Wolk, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281685 · Cited by 26
“As the main psychoactive component in tobacco and e-cigarettes, the pharmacological mode of action of nicotine on the central and the peripheral nervous system is well investigated (16).”
BackgroundLinazasoro, G. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181634ea6 · Cited by 25
“In addition, findings from molecular studies performed in brains of addicted animals and human beings state that molecular changes start in the ventral (limbic) striatum, but they progressively affect more dorsal (associative and motor) parts of the nucleus.(23) This gradient could explain the late development of moto…”
BackgroundWang, G., & Griškova-Bulanova, I. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.03.025 · Cited by 25
Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry
Popova, D., Desai, N., Blendy, J. A., & Pang, Z. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2317-18.2019 · Cited by 25
“The subsequent increase of dopamine in the Acb is associated with drug reward and reinforcement (Nestler, 2005; Chen et al., 2015).”
BackgroundPinheiro, C. R., de Moura, E. G., Manhães, A. C., Fraga, M. C., Claudio-Neto, S., Abreu‐Villaça, Y., Oliveira, E., & Lisboa, P. C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.001 · Cited by 26
“…important for behaviors such as: motor activity, memory and learning (Saint-Cyr et al., 1995; Lalonde and Botez-Marquard, 1997; Graybiel, 1998; Yin and Knowlton, 2006), drug addiction (Nestler, 2005; Kreitzer and Malenka, 2008), and for the nonhedonic response to food intake (Volkow et al., 2002).”
BackgroundAltered spontaneous activity in young chronic cigarette smokers revealed by regional homogeneity
Tang, J., Liao, Y., Deng, Q., Liu, T., Chen, X., Wang, X., Xiang, X., Chen, H., & Hao, W. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-44 · Cited by 24
“This hypofunction of the frontal region [14] (e.”
BackgroundJohnson, B. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00545 · Cited by 27
Baumung, C., Rehm, J. T., Franke, H., & Lachenmeier, D. W. (2016) · Scientific Reports · doi:10.1038/srep35577 · Cited by 24
García‐Cabrerizo, R., & García-Fuster, M. J. (2017) · Addiction Biology · doi:10.1111/adb.12593 · Cited by 24
“…that underlie the acute effects of methamphetamine are well understood (i.e. reinforcing effects through activation of the reward system; e.g. Nestler 2005), its recreational use is often characterized by a pattern of repeated frequent drug administrations during a short period of time (i.e.…”
BackgroundZhu, W. M., Mantione, K. J., Casares, F. M., Cadet, P., Kim, J. W., Bilfinger, T. V., Kream, R. M., Khalill, S., Singh, S., & Stefano, G. B. (2006) · PubMed · Cited by 24
Metadata
- Authors
- Nestler, E. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Nestler, Eric J
- ORCID
- Nestler, Eric J
- Venue
- Nature Neuroscience
- Published
- 2005-10-26
- Volume
- 8
- Issue
- 11
- Pages
- 1445-1449
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1988182239
- Cited by
- 1,388
- References
- 53
- Citations by year
- 2026: 22 · 2025: 47 · 2024: 54 · 2023: 57 · 2022: 49 · 2021: 56 · 2020: 62 · 2019: 70 · 2018: 61 · 2017: 66 · 2016: 72 · 2015: 81 · 2014: 86 · 2013: 94 · 2012: 79
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- addiction, drugs of abuse, brain reward system, chronic drug administration, acute drug effects, natural reward, addiction treatment
- MeSH terms
- Animals, Humans, Models, Neurological, Nerve Net, Reward, Behavior, Addictive, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.